[Progression of treatment of hepatitis C--peginterferon]

Przegl Epidemiol. 2001:55 Suppl 3:169-73.
[Article in Polish]
No abstract available

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Clinical Trials, Phase III as Topic
  • Hepatitis C / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha* / therapeutic use*
  • Polyethylene Glycols*
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins
  • Research Design

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2b
  • peginterferon alfa-2a